David Schweer
Overview
Explore the profile of David Schweer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wei Y, Erfani S, Schweer D, de Gouvea R, Qadir J, Shi J, et al.
Mol Ther Oncolytics
. 2023 Mar;
28:293-306.
PMID: 36911068
Epithelial ovarian cancer (EOC) remains one of the leading causes of cancer-related deaths among women worldwide. Receptor tyrosine kinases (RTKs) have long been sought as therapeutic targets for EOC, as...
2.
Schweer D, Anand N, Anderson A, McCorkle J, Neupane K, Nail A, et al.
Front Oncol
. 2023 Jan;
12:1042730.
PMID: 36713536
Background: Ovarian cancer is a deadly female malignancy with a high rate of recurrent and chemotherapy-resistant disease. Tumor-associated macrophages (TAMs) are a significant component of the tumor microenvironment and include...
3.
Bhosale S, Mandal A, Hou C, McCorkle J, Schweer D, Hill K, et al.
ChemMedChem
. 2022 Nov;
18(3):e202200368.
PMID: 36342449
DNA coordinating platinum (Pt) containing compounds cisplatin and carboplatin have been used for the treatment of ovarian cancer therapy for four decades. However, recurrent Pt-resistant cancers are a major cause...
4.
Schweer D, McAtee A, Neupane K, Richards C, Ueland F, Kolesar J
Cancers (Basel)
. 2022 May;
14(9).
PMID: 35565348
The tumor microenvironment (TME) has been implicated to play an important role in the progression of ovarian cancer. One of the most important components of the TME is tumor associated...
5.
Schweer D, McCorkle J, Rohr J, Tsodikov O, Ueland F, Kolesar J
Biomedicines
. 2021 Jan;
9(1).
PMID: 33445667
Ovarian cancer is a highly deadly malignancy in which recurrence is considered incurable. Resistance to platinum-based chemotherapy bodes a particularly abysmal prognosis, underscoring the need for novel therapeutic agents and...
6.
Carbajal-Mamani S, Dideban B, Schweer D, Balavage K, Chuang L, Wang Y, et al.
J Robot Surg
. 2020 Jun;
15(3):343-348.
PMID: 32592139
Robotic surgery for gynecologic malignancy is associated with a lower rate of venous thromboembolism (VTE) than laparotomy. Obese patients represent a particularly high-risk group for VTE, but prior studies tend...
7.
Carbajal-Mamani S, Schweer D, Markham M, Esnakula A, Grajo J, Castagno J, et al.
Obstet Gynecol Sci
. 2020 Mar;
63(2):150-157.
PMID: 32206654
Objective: The primary objective was to assess the feasibility of robotic-assisted interval cytoreductive surgery for achieving complete cytoreduction for patients with advanced-stage ovarian cancer. The secondary objective was to examine...
8.
Schweer D, Carmouche J, Jupiter D, Ball T, Clements J
J Foot Ankle Surg
. 2016 Sep;
55(6):1210-1215.
PMID: 27614827
The interrelationship between diabetes mellitus and cardiovascular disease is well-documented, and, secondary to the latter, is the use of antiplatelet therapy. Although diabetes and the associated vascular manifestations are driving...